{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:17:40Z","timestamp":1789449460109,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T00:00:00Z","timestamp":1430179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12883-015-0325-1","type":"journal-article","created":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T20:33:52Z","timestamp":1430166832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada"],"prefix":"10.1186","volume":"15","author":[{"given":"Allen R","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calum J","family":"Redpath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"van Walraven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,28]]},"reference":[{"key":"325_CR1","unstructured":"Statistics Canada: The Canadian Population in 2011:Age and Sex. 2012; Statistics Canada: www.statcan.gc.ca Catalogue No. 98-311-X2011001."},{"key":"325_CR2","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","volume":"366","author":"CP Ferri","year":"2005","unstructured":"Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112\u20137.","journal-title":"Lancet"},{"key":"325_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2165\/00003495-200161010-00005","volume":"61","author":"J Grutzendler","year":"2001","unstructured":"Grutzendler J, Morris JC. Cholinesterase inhibitors for Alzheimer\u2019s disease. Drugs. 2001;61:41\u201352.","journal-title":"Drugs"},{"key":"325_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0924-977X(00)00067-5","volume":"10","author":"SL Rogers","year":"2000","unstructured":"Rogers SL, Doody RS, Pratt RD, Ieni JR. Long-term efficacy and safety of donepezil in the treatment of Alzheimer\u2019s disease: final analysis of a US multicentre open-label study. Eur Neuropsychopharmacol. 2000;10:195\u2013203.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"325_CR5","first-page":"CD005593","volume":"25","author":"J Birks","year":"2006","unstructured":"Birks J. Cholinesterase inhibitors for Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2006;25(1):CD005593.","journal-title":"Cochrane Database Syst Rev"},{"key":"325_CR6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/emj.2006.036251","volume":"23","author":"T Suleyman","year":"2006","unstructured":"Suleyman T, Tevfik P, Abdulkadir G, Ozlem S. Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil. Emerg Med J. 2006;23:641\u20132.","journal-title":"Emerg Med J"},{"key":"325_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1099-5129(03)00080-1","volume":"5","author":"P Bordier","year":"2003","unstructured":"Bordier P, Garrigue S, Barold SS, Bressolles N, Lanusse S, Clementy J. Significance of syncope in patients with Alzheimer\u2019s disease treated with cholinesterase inhibitors. Europace. 2003;5:429\u201331.","journal-title":"Europace"},{"key":"325_CR8","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1345\/aph.18273","volume":"33","author":"G Shepherd","year":"1999","unstructured":"Shepherd G, Klein-Schwartz W, Edwards R. Donepezil overdose: a tenfold dosing error. Ann Pharmacother. 1999;33:812\u20135.","journal-title":"Ann Pharmacother"},{"key":"325_CR9","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.33588\/rn.2811.99025","volume":"28","author":"JM Calvo-Romero","year":"1999","unstructured":"Calvo-Romero JM, Ramos-Salado JL. [Symptomatic sinus bradycardia associated with donepezil]. Rev Neurol. 1999;28:1070\u20132.","journal-title":"Rev Neurol"},{"key":"325_CR10","doi-asserted-by":"publisher","first-page":"e1000157","DOI":"10.1371\/journal.pmed.1000157","volume":"6","author":"LY Park-Wyllie","year":"2009","unstructured":"Park-Wyllie LY, Mamdani MM, Li P, Gill SS, Laupacis A, Juurlink DN. Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study. PLoS Med. 2009;6:e1000157.","journal-title":"PLoS Med"},{"key":"325_CR11","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1111\/j.1532-5415.2009.02488.x","volume":"57","author":"RK Hernandez","year":"2009","unstructured":"Hernandez RK, Farwell W, Cantor MD, Lawler EV. Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system. J Am Geriatr Soc. 2009;57:1997\u20132003.","journal-title":"J Am Geriatr Soc"},{"key":"325_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.amjopharm.2012.11.002","volume":"10","author":"E Kroger","year":"2012","unstructured":"Kroger E, Berkers M, Carmichael PH, Souverein P, van Marum R, Egberts T. Use of rivastigmine or galantamine and risk of adverse cardiac events: a database study from the Netherlands. Am J Geriatr Pharmacother. 2012;10:373\u201380.","journal-title":"Am J Geriatr Pharmacother"},{"key":"325_CR13","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/archinternmed.2009.43","volume":"169","author":"SS Gill","year":"2009","unstructured":"Gill SS, Anderson GM, Fischer HD, Bell CM, Li P, Normand SL, et al. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study. Arch Intern Med. 2009;169:867\u201373.","journal-title":"Arch Intern Med"},{"key":"325_CR14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1017\/S1041610207006680","volume":"20","author":"D Ames","year":"2008","unstructured":"Ames D, Kaduszkiewicz H, van den Bussche H, Zimmermann T, Birks J, Ashby D. For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer\u2019s disease convincing or not? Int Psychogeriatr. 2008;20:259\u201392.","journal-title":"Int Psychogeriatr"},{"key":"325_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0895-4356(03)00246-4","volume":"57","author":"M Wilchesky","year":"2004","unstructured":"Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004;57:131\u201341.","journal-title":"J Clin Epidemiol"},{"key":"325_CR16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0895-4356(02)00452-3","volume":"55","author":"J Taylor","year":"2002","unstructured":"Taylor J, Fillenbaum GG, Ezell ME. The accuracy of medicare claims data in identifying Alzheimer\u2019s disease. J Clin Epidemiol. 2002;55:929\u201337.","journal-title":"J Clin Epidemiol"},{"key":"325_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/j.1552-4604.1984.tb01822.x","volume":"24","author":"EMV Williams","year":"1984","unstructured":"Williams EMV. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol. 1984;24:129\u201347.","journal-title":"J Clin Pharmacol"},{"key":"325_CR18","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1080\/01621459.1989.10478868","volume":"84","author":"PR Rosenbaum","year":"1989","unstructured":"Rosenbaum PR. Optimal matching for observational studies. J Am Stat Assoc. 1989;84:1024\u201332.","journal-title":"J Am Stat Assoc"},{"key":"325_CR19","first-page":"273","volume-title":"Categorical data analysis using the SAS system","author":"ME Stokes","year":"2000","unstructured":"Stokes ME, Davis CS, Koch GG. Conditional logisitic regression. In: Categorical data analysis using the SAS system. 1st ed. Cary, N.C.: SAS Institute Inc; 2000. p. 273\u2013322.","edition":"1"},{"key":"325_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0735-1097(02)02709-2","volume":"41","author":"V Essebag","year":"2003","unstructured":"Essebag V, Hadjis T, Platt RW, Pilote L. Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction. J Am Coll Cardiol. 2003;41:249\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"325_CR21","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1001\/archinte.167.15.1648","volume":"167","author":"V Essebag","year":"2007","unstructured":"Essebag V, Reynolds MR, Hadjis T, Lemery R, Olshansky B, Buxton AE, et al. Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med. 2007;167:1648\u201353.","journal-title":"Arch Intern Med"},{"key":"325_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cjca.2010.11.001","volume":"27","author":"AM Gillis","year":"2011","unstructured":"Gillis AM, Verma A, Talajic M, Nattel S, Dorian P. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. Can J Cardiol. 2011;27:47\u201359.","journal-title":"Can J Cardiol"},{"issue":"127","key":"325_CR23","first-page":"e283","volume":"2013","author":"AE Epstein","year":"2012","unstructured":"Epstein AE, DiMarco JP, Ellenbogen KA, Estes III NA, Freedman RA, Gettes LS, et al. ACCF\/AHA\/HRS focused update incorporated into the ACCF\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2012;2013(127):e283\u2013352.","journal-title":"Circulation"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-015-0325-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0325-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0325-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0325-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:12:57Z","timestamp":1748362377000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-015-0325-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,28]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1186\/s12883-015-0325-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,28]]},"assertion":[{"value":"4 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"66"}}